HA-1–targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantationElizabeth F. Krakow, Marie Bleakley, Melinda A. Biernacki et al.|Blood|2024Cited by 29
Phase I Study of Adoptive Immunotherapy with HA-1-Specific CD8+ and CD4+ Memory T Cells for Children and Adults with Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Trial in ProgressElizabeth F. Krakow, Marie Bleakley, Corinne Summers et al.|Blood|2020Cited by 6